Search Follow us

Carmat (ALCAR)

Business description

Carmat is developing a biocompatible, artificial heart to satisfy the lack of donor hearts available for terminal heart failure patients. The development process combines the expertise of a wide range of technical and medical experts.

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 12/02/2015

Edison's research is freely available. We will never ask for your credit card details and you do not need to register. By downloading this research you are agreeing to our terms and conditions, which you can read in full here.

Stock data

Market cap.€234.4m
Last close€26.000
High / Low (52 weeks)€28.3 / €19.8
Stock market listingEG
Forecast net cash (€m)54.5
Forecast gearing ratio (%)N/A
SectorPharmaceutical & healthcare

Price performance

Relative *

* % Relative to local index

Company news